Q

Qingdao NovelBeam Technology Co Ltd
SSE:688677

Watchlist Manager
Qingdao NovelBeam Technology Co Ltd
SSE:688677
Watchlist
Price: 35.68 CNY -7.76% Market Closed
Market Cap: 4.3B CNY
Have any thoughts about
Qingdao NovelBeam Technology Co Ltd?
Write Note

Qingdao NovelBeam Technology Co Ltd
Additional Paid In Capital

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Qingdao NovelBeam Technology Co Ltd
Additional Paid In Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Additional Paid In Capital CAGR 3Y CAGR 5Y CAGR 10Y
Q
Qingdao NovelBeam Technology Co Ltd
SSE:688677
Additional Paid In Capital
ÂĄ655.8m
CAGR 3-Years
310%
CAGR 5-Years
51%
CAGR 10-Years
N/A
A
APT Medical Inc
SSE:688617
Additional Paid In Capital
ÂĄ724m
CAGR 3-Years
66%
CAGR 5-Years
46%
CAGR 10-Years
N/A
J
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
Additional Paid In Capital
ÂĄ2B
CAGR 3-Years
3%
CAGR 5-Years
2%
CAGR 10-Years
40%
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
Additional Paid In Capital
ÂĄ6.9B
CAGR 3-Years
-5%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
J
Jafron Biomedical Co Ltd
SZSE:300529
Additional Paid In Capital
ÂĄ711.8m
CAGR 3-Years
10%
CAGR 5-Years
4%
CAGR 10-Years
N/A
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
Additional Paid In Capital
ÂĄ13.9B
CAGR 3-Years
64%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Qingdao NovelBeam Technology Co Ltd
Glance View

Market Cap
4.3B CNY
Industry
Health Care

Qingdao NovelBeam Technology Co., Ltd. engages in the research and development of optics technology, the manufacture of optical instruments, and the provision of design solutions for medical, life science, laser, and micro-display projection applications. The company is headquartered in Qingdao, Shandong and currently employs 854 full-time employees. The company went IPO on 2021-02-26. Its main products of medical endoscope equipment include fluorescent endoscopes, fluorescent camera adapters/adaptive lenses, fluorescent light source modules and white light source modules. Its medical endoscopic equipment products are mainly used in abdominal endoscopic surgery such as liver and gallbladder and gastrointestinal surgery. Its optical products mainly include medical optical products, industrial and laser optical products, and biometric products. Among them, the biometric products include fingerprint devices, palmprint devices and related accessories. In addition, the Company also provides technical services and house leasing services. The firm distributes its products both in the domestic market and to overseas markets.

Intrinsic Value
56.99 CNY
Undervaluation 37%
Intrinsic Value
Price
Q

See Also

What is Qingdao NovelBeam Technology Co Ltd's Additional Paid In Capital?
Additional Paid In Capital
655.8m CNY

Based on the financial report for Dec 31, 2023, Qingdao NovelBeam Technology Co Ltd's Additional Paid In Capital amounts to 655.8m CNY.

What is Qingdao NovelBeam Technology Co Ltd's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 5Y
51%

Over the last year, the Additional Paid In Capital growth was -5%. The average annual Additional Paid In Capital growth rates for Qingdao NovelBeam Technology Co Ltd have been 310% over the past three years , 51% over the past five years .

Back to Top